---
title: "Probiotics — Evidence & Citations | Magellan"
description: "Natural sources, dosing and cited research for Probiotics. Probiotics are live microorganisms that, when administered in adequate amounts, are intended…"
url: "https://magellanlongevity.com/m/probiotics.md"
canonical: "https://magellanlongevity.com/m/probiotics.html"
html: "https://magellanlongevity.com/m/probiotics.html"
type: "molecule"
slug: "probiotics"
evidence_grade: "Moderate evidence"
evidence_tier: "moderate"
citations: 24
updated: 2026-08-11
author: "Gabriel Radu, DO"
author_credentials: "Physiatrist (PM&R). NY medical license 275110. NPI 1376861765."
publisher: "Magellan Longevity"
content_format: "markdown"
---

# Probiotics

[Home](https://magellanlongevity.com/) › Molecules › Probiotics

**HTML version:** https://magellanlongevity.com/m/probiotics.html · **In the Magellan app:** https://magellanlongevity.com/#/search/Probiotics

## What it is

Probiotics are live microorganisms that, when administered in adequate amounts, are intended to confer a health benefit on the host. Multi-strain formulations combine several bacterial species—most commonly strains of Lactobacillus and Bifidobacterium—delivered at doses measured in colony-forming units (CFU), with high-potency products supplying tens of billions of CFU per serving. They are thought to act by modulating the composition and metabolic activity of the gut microbiota, reinforcing the intestinal epithelial barrier, producing short-chain fatty acids, and interacting with the host immune system and the gut-brain axis.

## What the human evidence shows

The strongest human evidence is indication-specific: a Cochrane review of 31 trials (8,672 participants) found probiotics cut the risk of Clostridioides difficile-associated diarrhea during antibiotic use by about 60% (1.5% vs 4.0%), and another Cochrane review found they modestly reduced the incidence and duration of acute upper respiratory infections. Beyond that, randomized trials and meta-analyses show measurable but generally modest benefits for glycemic control in type 2 diabetes, intestinal barrier integrity, and symptoms of depression, anxiety and stress, while relief in irritable bowel syndrome is strain-selective and low-certainty. In older adults the most consistent finding is a favorable shift in gut microbiota composition, with more variable immune, cognitive and metabolic effects. Notably, a systematic review matching single strains against mixtures within the same indication found multi-strain products are not inherently superior—effects depend on the exact strains and dose, and commercial blends rarely match the studied formulations. Probiotics are generally safe in healthy people, but live-organism products have rarely caused invasive infection in vulnerable hosts such as critically ill or immunocompromised people and preterm infants. This evidence describes probiotic microorganisms and their mechanisms in general, not this specific commercial multi-strain product.

## Evidence grade: Moderate evidence

- **Dose used in studies:** Human trials commonly use about 1–50 billion CFU/day (often 10^9–10^10), with many multi-strain products at 10–25 billion CFU; some high-potency formulas reach 100+ billion.
- **Dose from food:** Fermented foods supply live cultures: kefir roughly 10–30 billion CFU per cup and yogurt about 1–10 billion per serving, so a daily serving can match lower-dose supplements but with fewer, undefined strains.
- **Caveat:** Evidence is indication-specific: moderate-certainty Cochrane support for preventing antibiotic-associated and C. difficile diarrhea and for reducing respiratory infections, but IBS and general wellness benefits are low-certainty and strain-specific. Multi-strain, high-CFU blends are not proven better than single strains, and commercial formulas rarely match the studied ones. Generally safe in healthy people; rare invasive infections have occurred in vulnerable hosts.

## Where it comes from without a bottle

Food, exercise and behaviour routes to the same pathway, each with its citation.

| Natural source | How it works | Citation |
| --- | --- | --- |
| Fermented foods (yogurt, kefir, sauerkraut, kimchi) | A diet rich in fermented foods delivers live microbes and their metabolites the same way a probiotic capsule does; in a Stanford trial it raised gut-microbiome diversity and lowered inflammation. | Cell 2021 [PMID 34256014](https://pubmed.ncbi.nlm.nih.gov/34256014/) |
| Cultured / fermented milk (yogurt strains) | Multi-strain fermented milk carries Lactobacillus and yogurt cultures; in a randomized trial the probiotic strains showed up in the stool only while people were eating the product. | Sci Rep 2020 [PMID 32994487](https://pubmed.ncbi.nlm.nih.gov/32994487/) |
| Plant fiber to feed your own microbes | Beyond swallowing bacteria, feeding the microbes you already have with plant fiber reshapes the gut community; a high-fiber arm expanded carbohydrate-digesting microbial enzymes. | Cell 2021 [PMID 34256014](https://pubmed.ncbi.nlm.nih.gov/34256014/) |

### What those papers actually say

1. **Fermented foods (yogurt, kefir, sauerkraut, kimchi)**
   Cell 2021 · [PMID 34256014](https://pubmed.ncbi.nlm.nih.gov/34256014/) · [DOI 10.1016/j.cell.2021.06.019](https://doi.org/10.1016/j.cell.2021.06.019)

   > the high-fermented-food diet steadily increased microbiota diversity and decreased inflammatory markers

2. **Cultured / fermented milk (yogurt strains)**
   Sci Rep 2020 · [PMID 32994487](https://pubmed.ncbi.nlm.nih.gov/32994487/) · [DOI 10.1038/s41598-020-72161-w](https://doi.org/10.1038/s41598-020-72161-w)

   > Probiotic candidate strains were detected only during consumption period

3. **Plant fiber to feed your own microbes**
   Cell 2021 · [PMID 34256014](https://pubmed.ncbi.nlm.nih.gov/34256014/) · [DOI 10.1016/j.cell.2021.06.019](https://doi.org/10.1016/j.cell.2021.06.019)

   > The high-fiber diet increased microbiome-encoded glycan-degrading carbohydrate active enzymes (CAZymes) despite stable microbial community diversity

## Products built on Probiotics

| Product | Evidence grade | Typical price |
| --- | --- | --- |
| [Probiotic Multi-Strain (50B CFU)](https://magellanlongevity.com/p/199.md) | Moderate evidence | $16.99 |

## The research

### Cited studies

1. **Potential Modulation of Inflammation by Probiotic and Omega-3 Supplementation in Elderly with Chronic Low-Grade Inflammation: A Randomized, Placebo-Controlled Trial**
   Nutrients 2022 · [PMID 36235651](https://pubmed.ncbi.nlm.nih.gov/36235651/)

   > In older adults, multi-strain probiotic supplementation raised the anti-inflammatory cytokine IL-10 and short-chain fatty acids, although hs-CRP did not differ from placebo.

2. **Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study**
   Nature Medicine 2019 · [PMID 31263284](https://pubmed.ncbi.nlm.nih.gov/31263284/) · [DOI 10.1038/s41591-019-0495-2](https://doi.org/10.1038/s41591-019-0495-2)

   > Akkermansia muciniphila supplementation was safe and well tolerated and improved insulin sensitivity and markers of metabolic health in overweight, insulin-resistant adults.

3. **Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.**
   Gastroenterology 2023 · [PMID 37541528](https://pubmed.ncbi.nlm.nih.gov/37541528/) · [DOI 10.1053/j.gastro.2023.07.018](https://doi.org/10.1053/j.gastro.2023.07.018)

   > For abdominal pain, there was low certainty in the evidence for a benefit of Saccharomyces cerevisae I-3856 and Bifidobacterium strains, and very low certainty for combination probiotics, Lactobacillus, Saccharomyces, and Bacillus strains.

4. **Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.**
   Front Cell Infect Microbiol 2022 · [PMID 35433498](https://pubmed.ncbi.nlm.nih.gov/35433498/) · [DOI 10.3389/fcimb.2022.859967](https://doi.org/10.3389/fcimb.2022.859967)

   > B.coagulans exhibited the highest probability to be the optimal probiotic specie in improving IBS symptom relief rate, as well as global symptom, abdominal pain, bloating, and straining scores.

5. **Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.**
   Aliment Pharmacol Ther 2018 · [PMID 30294792](https://pubmed.ncbi.nlm.nih.gov/30294792/) · [DOI 10.1111/apt.15001](https://doi.org/10.1111/apt.15001)

   > Particular combinations of probiotics, or specific species and strains, appeared to have beneficial effects on global IBS symptoms and abdominal pain, but it was not possible to draw definitive conclusions about their efficacy.

6. **Meta-analysis of randomized controlled trials of the effects of probiotics on type 2 diabetes in adults.**
   Clin Nutr 2021 · [PMID 34999331](https://pubmed.ncbi.nlm.nih.gov/34999331/) · [DOI 10.1016/j.clnu.2021.11.037](https://doi.org/10.1016/j.clnu.2021.11.037)

   > Compared with single-strain and low-dose probiotics, multi-strain and high-dose probiotics have a greater beneficial effect on glycemic homeostasis. In addition, probiotic treatment may be more effective in patients with a high baseline body mass index and age.

7. **Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials.**
   Nutr Rev 2025 · [PMID 39731509](https://pubmed.ncbi.nlm.nih.gov/39731509/) · [DOI 10.1093/nutrit/nuae177](https://doi.org/10.1093/nutrit/nuae177)

   > Probiotics demonstrated a significant reduction in depression symptoms (SMD: -0.96; 95% CI: -1.31, -0.61) and a moderate reduction in anxiety symptoms (SMD: -0.59; 95% CI: -0.98, -0.19).

8. **Efficacy of probiotics on stress in healthy volunteers: A systematic review and meta-analysis based on randomized controlled trials.**
   Brain Behav 2020 · [PMID 32662591](https://pubmed.ncbi.nlm.nih.gov/32662591/) · [DOI 10.1002/brb3.1699](https://doi.org/10.1002/brb3.1699)

   > Current evidence suggests that probiotics can reduce subjective stress level in healthy volunteers and may alleviate stress-related subthreshold anxiety/depression level, without significant effect on cortisol level

9. **Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials.**
   Front Immunol 2023 · [PMID 37168869](https://pubmed.ncbi.nlm.nih.gov/37168869/) · [DOI 10.3389/fimmu.2023.1143548](https://doi.org/10.3389/fimmu.2023.1143548)

   > The present work revealed that probiotics could improve intestinal barrier function, and alleviate inflammation and microbial dysbiosis. Further high-quality RCTs are warranted to achieve a more definitive conclusion.

10. **Probiotics for the Prevention of Antibiotic-associated Diarrhea in Adults: A Meta-Analysis of Randomized Placebo-Controlled Trials.**
    J Clin Gastroenterol 2021 · [PMID 33234881](https://pubmed.ncbi.nlm.nih.gov/33234881/) · [DOI 10.1097/MCG.0000000000001464](https://doi.org/10.1097/MCG.0000000000001464)

    > Probiotics reduced the incidence of AAD by 38% (pooled relative risk, 0.62; 95% confidence interval, 0.51-0.74).

11. **Probiotics for the prevention of pediatric antibiotic-associated diarrhea.**
    Cochrane Database Syst Rev 2019 · [PMID 31039287](https://pubmed.ncbi.nlm.nih.gov/31039287/) · [DOI 10.1002/14651858.CD004827.pub5](https://doi.org/10.1002/14651858.CD004827.pub5)

    > An a priori available case subgroup analysis exploring heterogeneity indicated that high dose (≥ 5 billion CFUs per day) is more effective than low probiotic dose (< 5 billion CFUs per day), interaction P value = 0.01.

12. **Role of probiotic as adjuvant in treating various infections: a systematic review and meta-analysis.**
    BMC Infect Dis 2024 · [PMID 38773400](https://pubmed.ncbi.nlm.nih.gov/38773400/) · [DOI 10.1186/s12879-024-09259-3](https://doi.org/10.1186/s12879-024-09259-3)

    > This meta-analysis showed beneficial use of single strain probiotics as adjuvant therapy in eradicating H. pylori and the use of probiotics in UTI.

13. **The Effect of Probiotics on Health Outcomes in the Elderly: A Systematic Review of Randomized, Placebo-Controlled Studies.**
    Microorganisms 2021 · [PMID 34205818](https://pubmed.ncbi.nlm.nih.gov/34205818/) · [DOI 10.3390/microorganisms9061344](https://doi.org/10.3390/microorganisms9061344)

    > Probiotics appear to be efficacious in modifying gut microbiota composition in healthy older adults and have moderate effects on immune function.

14. **Impact of probiotics and prebiotics in the modulation of the major events of the aging process: A systematic review of randomized controlled trials.**
    Exp Gerontol 2022 · [PMID 35469958](https://pubmed.ncbi.nlm.nih.gov/35469958/) · [DOI 10.1016/j.exger.2022.111809](https://doi.org/10.1016/j.exger.2022.111809)

    > Overall, most interventions resulted in improvements in certain parameters when compared to control (glucose homeostasis, cognitive function, frailty phenotype, gut microbiota profile, immune parameters), while others remained unvariable.

15. **Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.**
    J Am Coll Nutr 2015 · [PMID 25909149](https://pubmed.ncbi.nlm.nih.gov/25909149/) · [DOI 10.1080/07315724.2014.983249](https://doi.org/10.1080/07315724.2014.983249)

    > The probiotic maintained CD4+ lymphocytes and produced a less inflammatory cytokine profile possibly due to the changes in the microbial communities, which more closely resembled those reported in healthy younger populations.

16. **Effects of Soluble Corn Fiber Alone or in Synbiotic Combination with LGG and the Pilus-Deficient Derivative GG-PB12 on Fecal Microbiota, Metabolism, and Markers of Immune Function: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Elderly (Saimes Study).**
    Front Immunol 2017 · [PMID 29312280](https://pubmed.ncbi.nlm.nih.gov/29312280/) · [DOI 10.3389/fimmu.2017.01443](https://doi.org/10.3389/fimmu.2017.01443)

    > We also found significant positive effects on the immune response, evidenced by a decrease of the pro-inflammatory cytokine IL-6.

17. **Effects of OLL2712 on Memory Function in Older Adults with Declining Memory: A Randomized Placebo-Controlled Trial.**
    Nutrients 2022 · [PMID 36296983](https://pubmed.ncbi.nlm.nih.gov/36296983/) · [DOI 10.3390/nu14204300](https://doi.org/10.3390/nu14204300)

    > The present study suggests that OLL2712 ingestion has protective effects against memory function decline in older adults.

18. **Probiotics, Prebiotics, Lactoferrin, and Combination Products for Prevention of Mortality and Morbidity in Preterm Infants: A Systematic Review and Network Meta-Analysis.**
    JAMA Pediatr 2023 · [PMID 37782505](https://pubmed.ncbi.nlm.nih.gov/37782505/) · [DOI 10.1001/jamapediatrics.2023.3849](https://doi.org/10.1001/jamapediatrics.2023.3849)

    > Only multiple-strain probiotics were associated with reduced all-cause mortality compared with placebo (risk ratio [RR], 0.69; 95% CI, 0.56 to 0.86; risk difference [RD], -1.7%; 95% CI, -2.4% to -0.8%).

19. **Do probiotics mitigate GI-induced inflammation and perceived fatigue in athletes? A systematic review.**
    J Int Soc Sports Nutr 2024 · [PMID 39193818](https://pubmed.ncbi.nlm.nih.gov/39193818/) · [DOI 10.1080/15502783.2024.2388085](https://doi.org/10.1080/15502783.2024.2388085)

    > Probiotic supplementation, specifically at a minimum dosage of 15 billion CFUs daily for a duration of at least 28 days, may contribute to the reduction of perceived or actual fatigue.

20. **Thirty Years of Lactobacillus rhamnosus GG: A Review.**
    J Clin Gastroenterol 2019 · [PMID 30741841](https://pubmed.ncbi.nlm.nih.gov/30741841/) · [DOI 10.1097/MCG.0000000000001170](https://doi.org/10.1097/MCG.0000000000001170)

    > Furthermore LGG is able to produces both a biofilm that can mechanically protect the mucosa, and different soluble factors beneficial to the gut by enhancing intestinal crypt survival, diminishing apoptosis of the intestinal epithelium, and preserving cytoskeletal integrity.

21. **Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.**
    The Cochrane database of systematic reviews 2017 · [PMID 29257353](https://pubmed.ncbi.nlm.nih.gov/29257353/)

    > Cochrane review of 31 RCTs (8,672 participants): probiotics cut the risk of C. difficile-associated diarrhea during antibiotic use by 60% (1.5% vs 4.0%; RR 0.40, moderate certainty).

22. **Probiotics for preventing acute upper respiratory tract infections.**
    The Cochrane database of systematic reviews 2022 · [PMID 36001877](https://pubmed.ncbi.nlm.nih.gov/36001877/)

    > Cochrane update: probiotics reduced the number of people diagnosed with at least one acute upper respiratory infection (RR 0.76) and shortened episodes by about 1.2 days.

23. **Efficacy of Single-Strain Probiotics Versus Multi-Strain Mixtures: Systematic Review of Strain and Disease Specificity.**
    Digestive diseases and sciences 2021 · [PMID 32274669](https://pubmed.ncbi.nlm.nih.gov/32274669/)

    > Systematic review of 65 RCTs (10,863 participants): multi-strain mixtures were not significantly more effective than single strains within the same indication in most cases.

24. **Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events.**
    United European gastroenterology journal 2016 · [PMID 27536365](https://pubmed.ncbi.nlm.nih.gov/27536365/)

    > Meta-analysis: multi-strain probiotic adjuncts improved H. pylori eradication rates and reduced antibiotic-associated side effects.

## Structured data

```json
{"@context":"https://schema.org","@graph":[{"@type":"MedicalWebPage","@id":"https://magellanlongevity.com/m/probiotics.html#page","url":"https://magellanlongevity.com/m/probiotics.html","name":"Probiotics","description":"Natural sources, dosing and cited research for Probiotics","inLanguage":"en","isPartOf":{"@type":"WebSite","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"author":{"@type":"Person","name":"Gabriel Radu, DO","jobTitle":"Physiatrist (PM&R)","identifier":[{"@type":"PropertyValue","name":"NPI","value":"1376861765"},{"@type":"PropertyValue","name":"NY medical license","value":"275110"}]},"publisher":{"@type":"Organization","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"encoding":{"@type":"MediaObject","encodingFormat":"text/markdown","contentUrl":"https://magellanlongevity.com/m/probiotics.md"},"dateModified":"2026-08-11"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://magellanlongevity.com/"},{"@type":"ListItem","position":2,"name":"Probiotics","item":"https://magellanlongevity.com/m/probiotics.html"}]},{"@type":"ItemList","@id":"https://magellanlongevity.com/m/probiotics.html#items","numberOfItems":1,"itemListElement":[{"@type":"ListItem","position":1,"name":"Probiotic Multi-Strain (50B CFU)","url":"https://magellanlongevity.com/p/199.html"}]}]}
```

## Related on Magellan Longevity

- [Probiotic Multi-Strain (50B CFU)](https://magellanlongevity.com/p/199.md)
- [Evidence-based longevity supplements](https://magellanlongevity.com/longevity-supplements.md)
- [Longevity research map](https://magellanlongevity.com/longevity-research-map.html)
- [Pathway universe](https://magellanlongevity.com/pathway-universe.html)

## Scope and disclosures

Educational information, not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if you are pregnant, nursing, or taking medication.

Editorial firewall: evidence grades are assigned from the published research and are independent of any affiliate commission. As an Amazon Associate, Magellan Longevity earns from qualifying purchases.

Reviewed for accuracy by a board-certified physician (DO).